Bespoke Extracts files Form 12b-25 for Q1 2026

Bespoke Extracts, Inc. notified the SEC that its Form 10-Q for the quarter ended March 31, 2026 was not filed on time and is being submitted under Rule 12b-25.

Rhea-AI Filing Summary

Bespoke Extracts, Inc. notified the SEC that its Form 10-Q for the quarter ended March 31, 2026 was not filed on time and is being submitted under Rule 12b-25. The company says it needs additional time to complete quarter-end closing procedures and expects to file within the five-calendar-day extension permitted by the rule.

The registrant estimates revenue for Q1 2026 was approximately $373,000, up from $263,159 for Q1 2025. The company cannot yet provide a reasonable estimate of its net loss because review of operating expenses and accruals remains incomplete.

Insights

Compliance Officer

Routine late-filing notice citing quarter-end close work; revenue estimate disclosed.

The filing uses Rule 12b-25 to notify the Commission of a delayed Form 10-Q for the period ended March 31, 2026, citing unfinished quarter-end closing procedures. The company states it expects to file within the five-calendar-day extension.

Key items to watch in the subsequent Form 10-Q are finalized net loss figures and reconciled operating expense accruals; timing is the five-day window stated.

Financial Controller

Provided revenue estimate shows year-over-year increase; net loss remains pending final close.

The company reports estimated revenue of $373,000 for Q1 2026 versus $263,159 for Q1 2025, attributing the rise to increased product sales. This is an operational datapoint disclosed in the notice.

Because expense accruals are incomplete, the ultimate impact on net loss is undetermined until the filed Form 10-Q provides final figures.

Key Figures

Estimated Q1 2026 Revenue: $373,000 Q1 2025 Revenue: $263,159 Filing extension window: five-calendar-day period +1 more

4 metrics

Estimated Q1 2026 Revenue $373,000 quarter ended March 31, 2026

Q1 2025 Revenue $263,159 quarter ended March 31, 2025

Filing extension window five-calendar-day period Rule 12b-25 for Form 10-Q

Notification signature date May 18, 2026 date on Form 12b-25 signature

Key Terms

Rule 12b-25, Form 10-Q, quarter-end closing procedures

3 terms

Rule 12b-25 regulatory

"expects to file its Form 10-Q within the five-calendar-day period permitted by Rule 12b-25"

Rule 12b-25 is an SEC filing provision that lets a company notify regulators and the public that it cannot file a required periodic report (like a quarterly or annual report) on time and explains the reason for the delay. For investors, the notice is a formal heads-up that financial information will arrive late—similar to a company calling to say it will be late turning in homework—so it signals increased uncertainty and may affect trading and risk assessments until the filing is available.

Form 10-Q regulatory

"complete the financial and other information required to be included in its Form 10-Q for the quarter ended March 31, 2026"

A Form 10-Q is a detailed report that publicly traded companies are required to file with regulators three times a year, providing an update on their financial health and business activities. It is important for investors because it offers timely insights into a company's performance, helping them make informed decisions about buying or selling stocks. Think of it as a regular check-up report that shows how well a company is doing.

quarter-end closing procedures financial

"requires additional time to complete its quarter-end closing procedures and finalize the compilation and review"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did Bespoke Extracts (BSPK) file a Form 12b-25?

The company filed to notify a late Form 10-Q because quarter-end closing procedures and final reviews were not complete; it expects to use the five-calendar-day extension under Rule 12b-25.

When does Bespoke expect to file the delayed Form 10-Q?

The company states it expects to file the Form 10-Q within the five-calendar-day period permitted by Rule 12b-25 after the prescribed due date, per the notification signed May 18, 2026.

What revenue did Bespoke report for Q1 2026 in the notice?

Bespoke estimates revenue for the quarter ended March 31, 2026 at approximately $373,000, up from $263,159 for the quarter ended March 31, 2025, citing increased product-line sales.

Did Bespoke provide an estimate for net loss for Q1 2026?

No. The company stated it is unable to provide a reasonable estimate of net loss for Q1 2026 because quarter-end closing and final review of operating expenses and accruals remain incomplete.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/18/2026 - 09:59 AM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

(Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR

For Period Ended: March 31, 2026

	☐	Transition Report on Form 10-K
	☐	Transition Report on Form 20-F
	☐	Transition Report on Form 11-K
	☐	Transition Report on Form 10-Q
	☐	Transition Report on Form N-CEN

For the Transition Period Ended: ________________________

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

PART I -- REGISTRANT INFORMATION

Bespoke Extracts, Inc.

Full Name of Registrant

Former Name if Applicable

12001 E. 33rd Avenue, Unit O

Address of Principal Executive Office (Street and Number)

Aurora, CO, 80010

City, State and Zip Code

PART II -- RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)

	(a)	The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
☒	(b)	The subject annual report, semi-annual report, transition report on Form 10-K, Form  20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed  on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the  prescribed due date; and
	(c)	The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III-- NARRATIVE

State below in reasonable detail why the Form 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR or the transition report portion thereof, could not be filed within the prescribed time period. (Attach extra sheets if needed.)

The Company requires additional time to complete its quarter-end closing procedures and finalize the compilation and review of the financial and other information required to be included in its Form 10-Q for the quarter ended March 31, 2026. These procedures could not be completed by the prescribed due date without unreasonable effort or expense. The Company currently expects to file its Form 10-Q within the five-calendar-day period permitted by Rule 12b-25.

PART IV -- OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification

Michael Feinsod		720		949-1143
(Name)		(Area Code)		(Telephone Number)

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s). ☒ Yes ☐ No

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☒ Yes ☐ No

If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

The Company estimates that revenue for the quarter ended March 31, 2026, increased to approximately $373,000 from $263,159 for the quarter ended March 31, 2025. The increase is due to increased sales across its product lines. The Company is unable at this time to provide a reasonable estimate of its net loss for the quarter ended March 31, 2026 because its quarter-end closing procedures and final review of operating expenses and related accruals have not yet been completed.

2

Bespoke Extracts, Inc.

(Name of Registrant as Specified in Charter)

Has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date: May 18, 2026	By:	/s/ Michael Feinsod
	Name:	Michael Feinsod
	Title:	Chief Executive Officer

3